1 Royal College of Psychiatrists . Consensus Statement on High-Dose Antipsychotic Medication (CR190). Royal College of Psychiatrists , 2014 .

2 National Institute for Health and Clinical Excellence . Psychosis and Schizophrenia in Adults: Treatment and Management (CG178). NICE , 2014 .

3 David , AS , Adams , C , Depot antipsychotic medication in the treatment of patients with schizophrenia: (1) Meta-review; (2) Patient and nurse attitudes . Health Technol Assess, 2001 ; 5 : 34 .

4 Taylor , PJ , Leese , M , Williams , D , Butwell , M , Daly , R , Larkin , E . Mental disorder and violence. A special (high security) hospital study . Br J Psychiatry 1998 ; 172 : 218–26.

5 Lelliot , P , Audini , B , Duffett , R . Survey of patients from an inner-London health authority in medium secure psychiatric care . Br J Psychiatry 2001 ; 178 : 62–6.

6 Paton , C , Lelliott , P , Harrington , M , Okacha , C , Sensky , T , Duffett , R . Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients . J Psychopharmacol 2003 ; 17 : 223–9.

7 Office for National Statistics . Ethnicity and National Identity in England and Wales: 2011. ONS , 2012 .

8 Pereira , S , Dawson , P , Sarsam , M . The National Survey of PICU and Low Secure Services: 1. Patient characteristics . J Psychiatr Intens Care 2006 ; 2 : 7 – 12 .

9 Taylor , D , Paton , C , Kapur , S . Maudsley Prescribing Guidelines (11th edition). Wiley-Blackwell , 2012 .

10 Lloyd , K , Moodley , P . Psychotropic medication and ethnicity: an inpatient survey . Soc Psychiatry Psychiatr Epidemiol 1992 ; 27 : 95 – 101 .

11 Connolly , A , Taylor , D . Ethnicity and quality of antipsychotic prescribing among inpatients in South London . Br J Psychiatry 2008 ; 193 : 161–2.

12 Kane , JM , Kishimoto , T , Correll , CU . Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry . J Clin Epidemiol 2013 ; 66 : S37 – 41 .

13 Hong , J , Novick , D , Brugnoli , R , Bertsch , J , Haro , JM . Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia . Hum Psychopharm Clin 2013 ; 28 : 438–46.

14 Zhu , B , Ascher-Svanum , H , Shi , L , Faries , D , Montgomery , W , Marder , SR . Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia . Psychiatr Serv 2008 ; 59 : 315–17.

15 Stone , DC , Niz , DO . Treatment considerations in the forensic patient with schizophrenia . Curr Pharm Design 2004 ; 10 : 2263–7.

16 Arango , C , Bombin , I , Gonzalez-Salvador , T , Garcia-Cabeza , I , Bobes , J . Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence . Eur Psychiat 2006 ; 21 : 34 – 40 .

17 Kirson , NY , Weiden , PJ , Yermakov , S , Huang , W , Samuelson , T , Offord , SJ , et al. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs . J Clin Psychiat 2013 ; 74 : 568–75.

18 Lafeuille , M , Laliberté-Auger , F , Lefebvre , P , Frois , C , Fastenau , J , Duh , MS . Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis . BMC Psychiatry 2013 ; 13 : 221 .

19 Johnson , DAW . Observations on the use of long-acting depot neuroleptic injections in the maintenance treatment of schizophrenia . J Clin Psychiat 1984 ; 45 : 13 – 21 .

20 Leucht , C , Heres , S , Kane , JM , Kissling , W , Davis , JM , Leucht , S . Oral versus depot antipsychotic drugs for schizophrenia: a critical systematic review and meta-analysis of randomised long-term trials . Schizophr Res 2011 ; 127 : 83 – 92 .

21 Haddad , PM , Chaudhry , IB , Husain , N , McLaughlin , S , Cunningham , P , David , AS , et al. Psychiatrists' attitudes to antipsychotic depot injections (i): Preferences and choice . Eur Psychiatry 2008 ; 23 : 160–1.

22 Potkin , S , Bera , R , Zubek , D , Lau , G . Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia . BMC Psychiatry 2013 ; 13 : 261 .

23 Caroli , F , Raymondet , P , Izard , I , Plas , J , Gall , B , Delgado , A , et al. Opinions of French patients with schizophrenia regarding injectable medication . Patient Prefer Adher 2011 ; 5 : 165–71.